E-LIB Suche - Ergebnisse für: Wasamoto, Satoshi - Sprache DE

OpenAccess-Volltexte X

Personensuche X

Sortierung: Relevanz

Sortierung: Jahr

1

Using the neutrophil‐to‐lymphocyte ratio to predict the out..:

Imai, Hisao ; Wasamoto, Satoshi ; Tsuda, Takeshi...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10481141/. , 2023

Link: http://www.ncbi.nlm.nih...

2

Post‐progression survival after atezolizumab plus carboplat..:

Masubuchi, Ken ; Imai, Hisao ; Wasamoto, Satoshi...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9527159/. , 2022

Link: http://www.ncbi.nlm.nih...

3

Real‐world data of atezolizumab plus carboplatin and etopos..:

Shiono, Ayako ; Imai, Hisao ; Wasamoto, Satoshi...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9844637/. , 2022

Link: http://www.ncbi.nlm.nih...

4

Predictive value of post‐treatment C‐reactive protein‐to‐al..:

Araki, Taisuke ; Tateishi, Kazunari ; Komatsu, Masamichi...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9284133/. , 2022

Link: http://www.ncbi.nlm.nih...

5

Efficacy and safety of amrubicin monotherapy after atezoliz..:

Imai, Hisao ; Nagai, Yoshiaki ; Minemura, Hiroyuki...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9395483/. , 2022

Link: http://www.ncbi.nlm.nih...

6

Wheezing and Weightlifting:

Yanagisawa, Satoru ; Wasamoto, Satoshi ; Takechi, Hiroki.
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8987239/. , 2021

Link: http://www.ncbi.nlm.nih...

7

Efficacy and safety of S‐1 monotherapy in previously treate..:

Imai, Hisao ; Minemura, Hiroyuki ; Kishikawa, Takayuki...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7529563/. , 2020

Link: http://www.ncbi.nlm.nih...

8

Pulmonary "Finger-in-glove" Sign on Fluorodeoxyglucose-posi..:

Yanagisawa, Satoru ; Wasamoto, Satoshi ; Endoh, Hideki
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6928516/. , 2019

Link: http://www.ncbi.nlm.nih...

9

Table_1_Pretreatment glasgow prognostic score predicts surv..:

Satoshi Wasamoto ; Hisao Imai ; Takeshi Tsuda...
doi:10.3389/fonc.2022.1080729.s001. , 2023

Link: https://doi.org/10.3389/..

10

Real‐world data of atezolizumab plus carboplatin and etopos..:

Ayako Shiono ; Hisao Imai ; Satoshi Wasamoto...
https://doi.org/10.1002/cam4.4938. , 2023

Link: https://doi.org/10.1002/..

11

Pretreatment glasgow prognostic score predicts survival amo..:

Satoshi Wasamoto ; Hisao Imai ; Takeshi Tsuda...
https://www.frontiersin.org/articles/10.3389/fonc.2022.1080729/full. , 2023

Link: https://doi.org/10.3389/..

12

Using the neutrophil‐to‐lymphocyte ratio to predict the out..:

Hisao Imai ; Satoshi Wasamoto ; Takeshi Tsuda...
https://doi.org/10.1111/1759-7714.15036. , 2023

Link: https://doi.org/10.1111/..

13

Post‐progression survival after atezolizumab plus carboplat..:

Ken Masubuchi ; Hisao Imai ; Satoshi Wasamoto...
https://doi.org/10.1111/1759-7714.14621. , 2022

Link: https://doi.org/10.1111/..

14

Predictive value of post‐treatment C‐reactive protein‐to‐al..:

Taisuke Araki ; Kazunari Tateishi ; Masamichi Komatsu...
https://doi.org/10.1111/1759-7714.14484. , 2022

Link: https://doi.org/10.1111/..

15

Efficacy and safety of S‐1 monotherapy in previously treate..:

Hisao Imai ; Hiroyuki Minemura ; Takayuki Kishikawa...
https://doi.org/10.1111/1759-7714.13622. , 2020

Link: https://doi.org/10.1111/..

1-15